{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Gallamine  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Gallamine. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Gallamine  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "gallamine",
    "trial_2_text": "Gallamine  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Gallamine Supplement: 60 participants will take Gallamine 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Gallamine. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Gallamine  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "78": 0.20557254552841187,
      "87": 0.19861677289009094,
      "177": 0.1325497180223465,
      "17": 0.12744778394699097,
      "20": 0.12011086195707321,
      "46": 0.11416725814342499,
      "123": 0.11347559839487076,
      "37": 0.10724884271621704,
      "9": 0.106699638068676,
      "173": 0.10363880544900894,
      "68": 0.10267931967973709,
      "77": 0.09992299228906631,
      "21": 0.098869688808918,
      "79": 0.09604018926620483,
      "189": 0.0861784890294075,
      "67": 0.0849442332983017,
      "49": 0.0844627171754837,
      "228": 0.08400484919548035,
      "200": 0.08135633170604706,
      "14": 0.07839325070381165,
      "188": 0.07282447814941406,
      "64": 0.06941505521535873,
      "243": 0.06911883503198624,
      "2": 0.06814998388290405,
      "350": 0.06801668554544449,
      "114": 0.06713275611400604,
      "104": 0.06405594199895859,
      "126": 0.06252316385507584,
      "180": 0.059496745467185974,
      "5": 0.05798263102769852,
      "29": 0.05790509283542633,
      "85": 0.056733645498752594,
      "101": 0.05661458149552345,
      "86": 0.0560232475399971,
      "239": 0.05534862354397774,
      "72": 0.05465061962604523,
      "193": 0.0546191930770874,
      "27": 0.052626702934503555,
      "28": 0.05174441635608673,
      "76": 0.05105581879615784,
      "122": 0.04836835712194443,
      "18": 0.047560032457113266,
      "139": 0.0459812767803669,
      "102": 0.04584381729364395,
      "179": 0.04557720944285393,
      "116": 0.04528367891907692,
      "147": 0.04482744261622429,
      "61": 0.0441715344786644,
      "151": 0.04389529302716255,
      "82": 0.041140858083963394,
      "69": 0.04053138196468353,
      "131": 0.04031887277960777,
      "396": 0.03961207717657089,
      "276": 0.039554573595523834,
      "194": 0.0392640046775341,
      "282": 0.038564007729291916,
      "38": 0.03830748796463013,
      "355": 0.037491630762815475,
      "30": 0.03701335936784744,
      "253": 0.03646604344248772,
      "261": 0.03627645969390869,
      "96": 0.03468189761042595,
      "144": 0.03464833274483681,
      "339": 0.03461658954620361,
      "191": 0.03408261016011238,
      "92": 0.0340515598654747,
      "204": 0.03344671428203583,
      "234": 0.033337824046611786,
      "75": 0.033169690519571304,
      "164": 0.03300352022051811,
      "35": 0.03217551112174988,
      "212": 0.03197458013892174,
      "288": 0.03169776871800423,
      "262": 0.031233880668878555,
      "286": 0.031069409102201462,
      "249": 0.030873436480760574,
      "508": 0.030697133392095566,
      "269": 0.03068975917994976,
      "121": 0.03048749640583992,
      "454": 0.030293848365545273,
      "466": 0.029605185613036156,
      "153": 0.02935001812875271,
      "132": 0.0292131956666708,
      "130": 0.028982648625969887,
      "97": 0.0288630872964859,
      "186": 0.02878638543188572,
      "166": 0.028741180896759033,
      "33": 0.02872125431895256,
      "441": 0.028553510084748268,
      "100": 0.02847600355744362,
      "382": 0.028439905494451523,
      "1": 0.028062360361218452,
      "163": 0.027965836226940155,
      "221": 0.0272750835865736,
      "257": 0.02721705101430416,
      "31": 0.027133837342262268,
      "4": 0.026896748691797256,
      "36": 0.026894135400652885,
      "211": 0.026754304766654968,
      "142": 0.026362812146544456
    },
    "trial_2_ae": {
      "78": 0.20557254552841187,
      "87": 0.19861677289009094,
      "177": 0.1325497180223465,
      "17": 0.12744778394699097,
      "20": 0.12011086195707321,
      "46": 0.11416725814342499,
      "123": 0.11347559839487076,
      "37": 0.10724884271621704,
      "9": 0.106699638068676,
      "173": 0.10363880544900894,
      "68": 0.10267931967973709,
      "77": 0.09992299228906631,
      "21": 0.098869688808918,
      "79": 0.09604018926620483,
      "189": 0.0861784890294075,
      "67": 0.0849442332983017,
      "49": 0.0844627171754837,
      "228": 0.08400484919548035,
      "200": 0.08135633170604706,
      "14": 0.07839325070381165,
      "188": 0.07282447814941406,
      "64": 0.06941505521535873,
      "243": 0.06911883503198624,
      "2": 0.06814998388290405,
      "350": 0.06801668554544449,
      "114": 0.06713275611400604,
      "104": 0.06405594199895859,
      "126": 0.06252316385507584,
      "180": 0.059496745467185974,
      "5": 0.05798263102769852,
      "29": 0.05790509283542633,
      "85": 0.056733645498752594,
      "101": 0.05661458149552345,
      "86": 0.0560232475399971,
      "239": 0.05534862354397774,
      "72": 0.05465061962604523,
      "193": 0.0546191930770874,
      "27": 0.052626702934503555,
      "28": 0.05174441635608673,
      "76": 0.05105581879615784,
      "122": 0.04836835712194443,
      "18": 0.047560032457113266,
      "139": 0.0459812767803669,
      "102": 0.04584381729364395,
      "179": 0.04557720944285393,
      "116": 0.04528367891907692,
      "147": 0.04482744261622429,
      "61": 0.0441715344786644,
      "151": 0.04389529302716255,
      "82": 0.041140858083963394,
      "69": 0.04053138196468353,
      "131": 0.04031887277960777,
      "396": 0.03961207717657089,
      "276": 0.039554573595523834,
      "194": 0.0392640046775341,
      "282": 0.038564007729291916,
      "38": 0.03830748796463013,
      "355": 0.037491630762815475,
      "30": 0.03701335936784744,
      "253": 0.03646604344248772,
      "261": 0.03627645969390869,
      "96": 0.03468189761042595,
      "144": 0.03464833274483681,
      "339": 0.03461658954620361,
      "191": 0.03408261016011238,
      "92": 0.0340515598654747,
      "204": 0.03344671428203583,
      "234": 0.033337824046611786,
      "75": 0.033169690519571304,
      "164": 0.03300352022051811,
      "35": 0.03217551112174988,
      "212": 0.03197458013892174,
      "288": 0.03169776871800423,
      "262": 0.031233880668878555,
      "286": 0.031069409102201462,
      "249": 0.030873436480760574,
      "508": 0.030697133392095566,
      "269": 0.03068975917994976,
      "121": 0.03048749640583992,
      "454": 0.030293848365545273,
      "466": 0.029605185613036156,
      "153": 0.02935001812875271,
      "132": 0.0292131956666708,
      "130": 0.028982648625969887,
      "97": 0.0288630872964859,
      "186": 0.02878638543188572,
      "166": 0.028741180896759033,
      "33": 0.02872125431895256,
      "441": 0.028553510084748268,
      "100": 0.02847600355744362,
      "382": 0.028439905494451523,
      "1": 0.028062360361218452,
      "163": 0.027965836226940155,
      "221": 0.0272750835865736,
      "257": 0.02721705101430416,
      "31": 0.027133837342262268,
      "4": 0.026896748691797256,
      "36": 0.026894135400652885,
      "211": 0.026754304766654968,
      "142": 0.026362812146544456
    }
  },
  "safety": {
    "trial_1_safety": 0.28165701031684875,
    "trial_2_safety": 0.28165701031684875
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47986409068107605
  }
}